Nordicus Partners Corp Files 10-Q for Period Ending December 31, 2023

TL;DR

<b>Nordicus Partners Corp has filed its Q3 2024 10-Q report, detailing financial performance and corporate information.</b>

AI Summary

Nordicus Partners Corp (NORD) filed a Quarterly Report (10-Q) with the SEC on February 6, 2024. Nordicus Partners Corp filed a 10-Q report for the period ending December 31, 2023. The filing covers the third quarter of fiscal year 2024. The company's fiscal year ends on March 31. Nordicus Partners Corp was formerly known as EKIMAS Corp, AdvanSource Biomaterials Corp, and CARDIOTECH INTERNATIONAL INC. The company's business address is 95 Washington Street #154, Canton, MA 02021.

Why It Matters

For investors and stakeholders tracking Nordicus Partners Corp, this filing contains several important signals. This 10-Q filing provides investors with an update on Nordicus Partners Corp's financial health and operational status for the third quarter of fiscal year 2024. Understanding the company's historical name changes and current business address is crucial for tracking its corporate evolution and identifying its operational base.

Risk Assessment

Risk Level: low — Nordicus Partners Corp shows low risk based on this filing. The filing is a standard 10-Q, which is a routine quarterly report and does not contain significant new information that would alter the risk profile.

Analyst Insight

Monitor future 10-Q filings for detailed financial performance and any changes in operational strategy.

Key Numbers

• 20231231 — CONFORMED PERIOD OF REPORT (10-Q)
• 20240206 — FILED AS OF DATE (10-Q)
• 0331 — FISCAL YEAR END (COMPANY DATA)
• 20200406 — DATE OF NAME CHANGE (FORMER COMPANY)
• 20081021 — DATE OF NAME CHANGE (FORMER COMPANY)
• 19960321 — DATE OF NAME CHANGE (FORMER COMPANY)
• 508-523-3141 — BUSINESS PHONE (COMPANY DATA)

Key Players & Entities

• Nordicus Partners Corp (company) — FILER
• EKIMAS Corp (company) — FORMER COMPANY
• AdvanSource Biomaterials Corp (company) — FORMER COMPANY
• CARDIOTECH INTERNATIONAL INC (company) — FORMER COMPANY
• 95 Washington Street #154 (location) — BUSINESS ADDRESS
• Canton (location) — CITY
• MA (location) — STATE
• 02021 (location) — ZIP

Forward-Looking Statements

• Nordicus Partners Corp will continue to report minimal to no revenue in the next fiscal quarter. (Nordicus Partners Corp) — high confidence, target: 2024-03-31
• The company will likely report another net loss in the upcoming fiscal quarter. (Nordicus Partners Corp) — high confidence, target: 2024-03-31

FAQ

Industry Context

Nordicus Partners Corp operates within the Management Consulting Services industry (SIC 8742). This filing is a standard quarterly report.

Regulatory Implications

The company is subject to SEC regulations for public companies, including the requirement to file quarterly reports (10-Q) under the Securities Exchange Act of 1934.

What Investors Should Do

1. Review the full 10-Q filing for detailed financial statements and management discussion.
2. Track future SEC filings for ongoing financial performance and strategic updates.
3. Research the company's historical performance under its previous names.

Key Dates

• 2023-12-31: End of Reporting Period — Third quarter of fiscal year 2024
• 2024-02-06: Filing Date — Date the 10-Q was filed with the SEC

Year-Over-Year Comparison

This is a 10-Q filing, which is a routine quarterly report. No prior filing data is available in this extract for comparison.

Key Financial Figures

• $0.001 — Section 12(g) of the Act: Common Stock, $0.001 par value per share Indicate by check

Filing Documents

• form10-q.htm (10-Q) — 496KB
• ex31-1.htm (EX-31.1) — 11KB
• ex31-2.htm (EX-31.2) — 12KB
• ex32-1.htm (EX-32.1) — 12KB
• 0001493152-24-005068.txt (&nbsp;) — 2547KB
• nord-20231231.xsd (EX-101.SCH) — 19KB
• nord-20231231_cal.xml (EX-101.CAL) — 29KB
• nord-20231231_def.xml (EX-101.DEF) — 93KB
• nord-20231231_lab.xml (EX-101.LAB) — 182KB
• nord-20231231_pre.xml (EX-101.PRE) — 149KB
• form10-q_htm.xml (XML) — 270KB

Notes to Consolidated Financial Statements (unaudited)

Notes to Consolidated Financial Statements (unaudited) 7 Item 2

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 12 Item 3

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 15 Item 4

Controls and Procedures

Controls and Procedures 15 PART II OTHER INFORMATION 16 Item 1.

Legal Proceedings

Legal Proceedings 16 Item 1A.

Risk Factors

Risk Factors 16 Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 16 Item 3 Defaults Upon Senior Securities 16 Item 4 Mine Safety Disclosures 16 Item 5 Other Information 16 Item 6 Exhibits 16

Signatures

Signatures 17 2 PART I - FINANCIAL INFORMATION Item 1. Unaudited Financial Statements NORDICUS PARTNERS CORPORATION AND SUBSIDIARY CONSOLIDATED BALANCE SHEETS December 31, 2023 March 31, 2023 (Unaudited) ASSETS Current assets: Cash $ 38,788 $ 7,149 Receivable — 44,481 Prepaids and other current assets — 770 Total current assets 38,788 52,400 Website 8,774 2,625 Investment in Myson, Inc. 1,750,000 — Total Assets $ 1,797,562 $ 55,025 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 37,451 $ 1,354 Accounts payable – related party — 12,127 Related party payable 25,521 13,886 Total current liabilities 62,972 27,367 Total Liabilities 62,972 27,367 Commitments and contingencies — — Stockholders' equity: Preferred stock; $ 0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding — — Common stock; $ 0.001 par value; 50,000,000 shares authorized; 10,976,248 and 8,296,248 shares issued; respectively 10,976 8,296 Treasury stock, 1,534 shares at cost ( 30,328 ) ( 30,328 ) Additional paid-in capital 44,173,233 42,246,688 Accumulated other comprehensive income ( 7,552 ) 665 Accumulated deficit ( 42,411,739 ) ( 42,197,663 ) Total stockholders' equity 1,734,590 27,658 Total liabilities and stockholders' equity $ 1,797,562 $ 55,025 The accompanying notes are an integral part of these unaudited consolidated financial statements. 3 NORDICUS PARTNERS CORPORATION AND SUBSIDIARY CONSOLIDATED (Unaudited) 2023 2022 2023 2022 For the Three Months Ended December 31, For the Nine Months Ended December 31, 2023 2022 2023 2022 Operating expenses: Officer compensation $ 30,158 $ — $ 87,751 $ — Stock based compensation– related party — 824,530 — 5,834,301 Professional fees 43,728 17,429 120,521 37,280 General and administrative 1,104 11,019 15,188

View Full Filing

View this 10-Q filing on SEC EDGAR